Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Q-Cells SE To File For Insolvency - Quick Facts

Q-Cells SE (QCLSF.PK) would file for insolvency proceedings on Tuesday, 3 April 2012, at the competent Insolvency Court in Dessau. Against the backdrop of the final ruling of the Frankfurt Higher Regional Court in the Pfleiderer case on March 27, 2012, the company had come to the conclusion that no going concern prognosis is given anymore.

After an intensive review of alternative concepts for the implementation of the financial restructuring, the Executive Board has concluded that a going concern of the company cannot be restored on a sufficiently secure legal basis. Hence, the filing for insolvency proceedings is legally necessary. The Executive Board and the preliminary insolvency administrator would work together to secure the continuity of the company within the insolvency proceedings.

Click here to receive FREE breaking news email alerts for Q-Cells SE and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved notably higher over the course of the trading day on Tuesday after recovering from an initial move to the downside. With the strong upward move on the day, the Dow reached a new record intraday high before giving back some ground. President Barack Obama is scheduled to travel to the headquarters of the Centers for Disease Control and Prevention in Atlanta, Georgia, on Tuesday to outline steps the U.S. will take to help combat the Ebola outbreak in West Africa. Senate Republicans once again voted Monday to block a Democratic bill aimed at narrowing the national gender wage gap. The Senate voted 52 to 40 in favor of limiting debate on the Paycheck Fairness Act, falling well short of the 60 votes required.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.